Browsing Tag
Nasdaq: ERNA
3 posts
Is Ernexa Therapeutics (NASDAQ: ERNA) turning into the next small‑cap biotech breakout?
Is Ernexa Therapeutics (NASDAQ: ERNA) the next small-cap biotech breakout? Learn how its iMSC platform and Cellipont partnership could change its trajectory.
Ernexa’s ERNA-101 cell therapy takes major step toward clinical trials through Cellipont manufacturing deal
Discover how Ernexa Therapeutics and Cellipont Bioservices are teaming up to manufacture ERNA-101 for ovarian cancer, marking a milestone in allogeneic cell therapy.
Ernexa Therapeutics (NASDAQ: ERNA) surges 68% after Cellipont deal to advance ovarian cancer cell therapy ERNA‑101
Ernexa Therapeutics stock jumps 68% after partnering with Cellipont to manufacture its ovarian cancer cell therapy ERNA-101. Learn what’s driving investor interest.